Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)

Clinical trial NCT02973113 · COMPLETED

Trial details

NCT number: NCT02973113
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NonHodgkin Lymphoma Lymphoproliferative Disorders EBV Related Lymphoma EBV-Related PTLD Hodgkin Lymphoma EBV Related Non-Hodgkin's Lymphoma EBV Related Hodgkin's Lymphoma

Start date: 2016-02-16
Primary completion: 2019-09-05
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.